ImmunoPrecise Antibodies (IPA) is an advanced biotherapeutic research and technology company utilizing artificial intelligence, high-throughput screening, and multi-species antibody discovery platforms. IPA delivers full-service, end-to-end therapeutic antibody discovery and engineering solutions, assisting global pharmaceutical clients in moving from target identification to optimized, developable lead candidates.
Subscribe to our newsletter
Subscribe to receive the latest news and innovations straight to your inbox.
Your subscription could not be saved. Please try again.
We use cookies for various purposes including to make your experience of our website better. Please confirm below that you consent to our use of non-essential cookies in accordance with our cookies policy. Click here to access our cookies policy and find out more about our cookie use and how to disable cookies.